| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 5.17e-05 | 28 | 148 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.27e-04 | 35 | 148 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.30e-04 | 66 | 148 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.58e-04 | 37 | 148 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | malate dehydrogenase (decarboxylating) (NADP+) activity | 1.63e-04 | 3 | 148 | 2 | GO:0004473 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | TYW3 EP400 RSF1 CHD1 DDX51 PIWIL2 MSH4 DCLRE1B RAD54L2 EXOSC2 CNOT6L INTS11 DDX3Y CMTR2 | 3.21e-04 | 645 | 148 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | malic enzyme activity | 3.24e-04 | 4 | 148 | 2 | GO:0004470 | |
| GeneOntologyMolecularFunction | oxaloacetate decarboxylase activity | 3.24e-04 | 4 | 148 | 2 | GO:0008948 | |
| GeneOntologyMolecularFunction | retinoid binding | 4.38e-04 | 48 | 148 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 4.74e-04 | 49 | 148 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | steroid binding | 4.74e-04 | 133 | 148 | 6 | GO:0005496 | |
| GeneOntologyMolecularFunction | thiol oxidase activity | 8.03e-04 | 6 | 148 | 2 | GO:0016972 | |
| GeneOntologyMolecularFunction | O-methyltransferase activity | 8.14e-04 | 25 | 148 | 3 | GO:0008171 | |
| GeneOntologyMolecularFunction | 7S RNA binding | 1.12e-03 | 7 | 148 | 2 | GO:0008312 | |
| GeneOntologyMolecularFunction | translation termination factor activity | 1.12e-03 | 7 | 148 | 2 | GO:0008079 | |
| GeneOntologyMolecularFunction | translation release factor activity | 1.12e-03 | 7 | 148 | 2 | GO:0003747 | |
| GeneOntologyMolecularFunction | malate dehydrogenase activity | 1.48e-03 | 8 | 148 | 2 | GO:0016615 | |
| GeneOntologyMolecularFunction | fatty acid binding | 1.72e-03 | 69 | 148 | 4 | GO:0005504 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.20e-08 | 5 | 146 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 3.57e-08 | 6 | 146 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 3.57e-08 | 6 | 146 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 3.57e-08 | 6 | 146 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 4.89e-07 | 10 | 146 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 4.89e-07 | 10 | 146 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 9.68e-07 | 26 | 146 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 9.68e-07 | 26 | 146 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.64e-06 | 13 | 146 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 3.44e-06 | 5 | 146 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.31e-05 | 21 | 146 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.31e-05 | 21 | 146 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 6.62e-05 | 60 | 146 | 5 | GO:0021587 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 7.29e-05 | 12 | 146 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 9.04e-05 | 64 | 146 | 5 | GO:0021575 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 9.47e-05 | 34 | 146 | 4 | GO:0006706 | |
| Domain | - | HEATR4 CKAP5 TOGARAM1 ZYG11B HEATR5A EFR3A RIF1 ARID1B ARVCF GCN1 AGTPBP1 | 1.40e-06 | 222 | 146 | 11 | 1.25.10.10 |
| Domain | ARM-like | HEATR4 CKAP5 TOGARAM1 ZYG11B HEATR5A EFR3A RIF1 ARID1B ARVCF GCN1 AGTPBP1 | 9.19e-06 | 270 | 146 | 11 | IPR011989 |
| Domain | UDPGT | 1.93e-05 | 21 | 146 | 4 | PF00201 | |
| Domain | UDPGT | 1.93e-05 | 21 | 146 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 1.93e-05 | 21 | 146 | 4 | IPR002213 | |
| Domain | Secretoglobin_1C1/2 | 6.07e-05 | 2 | 146 | 2 | IPR028659 | |
| Domain | ARM-type_fold | DOCK1 HEATR4 CKAP5 TOGARAM1 ZYG11B HEATR5A EFR3A RIF1 ARVCF GCN1 AGTPBP1 | 7.41e-05 | 339 | 146 | 11 | IPR016024 |
| Domain | Malic_OxRdtase | 1.81e-04 | 3 | 146 | 2 | IPR001891 | |
| Domain | Malic_NAD-bd | 1.81e-04 | 3 | 146 | 2 | IPR012302 | |
| Domain | Malic_N_dom | 1.81e-04 | 3 | 146 | 2 | IPR012301 | |
| Domain | MALIC_ENZYMES | 1.81e-04 | 3 | 146 | 2 | PS00331 | |
| Domain | Malic_M | 1.81e-04 | 3 | 146 | 2 | PF03949 | |
| Domain | Malic_M | 1.81e-04 | 3 | 146 | 2 | SM00919 | |
| Domain | malic | 1.81e-04 | 3 | 146 | 2 | PF00390 | |
| Domain | - | 1.81e-04 | 3 | 146 | 2 | 3.40.50.10380 | |
| Domain | malic | 1.81e-04 | 3 | 146 | 2 | SM01274 | |
| Domain | Malic_enzyme_CS | 1.81e-04 | 3 | 146 | 2 | IPR015884 | |
| Domain | HEAT_REPEAT | 2.19e-04 | 70 | 146 | 5 | PS50077 | |
| Domain | DUF1908 | 3.60e-04 | 4 | 146 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 3.60e-04 | 4 | 146 | 2 | IPR015022 | |
| Domain | MAST_pre-PK_dom | 3.60e-04 | 4 | 146 | 2 | IPR023142 | |
| Domain | - | 3.60e-04 | 4 | 146 | 2 | 1.20.1480.20 | |
| Domain | HEAT | 1.10e-03 | 58 | 146 | 4 | IPR000357 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.05e-06 | 28 | 108 | 5 | M19580 | |
| Pathway | WP_ESTROGEN_METABOLISM | 2.14e-05 | 22 | 108 | 4 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.08e-05 | 24 | 108 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.64e-05 | 25 | 108 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 3.64e-05 | 25 | 108 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.64e-05 | 25 | 108 | 4 | M605 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 4.27e-05 | 51 | 108 | 5 | M17726 | |
| Pathway | WP_GLUCURONIDATION | 4.28e-05 | 26 | 108 | 4 | M39404 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.69e-05 | 52 | 108 | 5 | M14171 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.50e-04 | 14 | 108 | 3 | M39328 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.18e-04 | 39 | 108 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.65e-04 | 41 | 108 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.81e-04 | 45 | 108 | 4 | MM15694 | |
| Pubmed | ST7 RNF213 ZYG11B ME1 CLCC1 IWS1 EFR3A FANCD2 RIF1 ARID1B STXBP3 ARVCF P4HB AHNAK INTS11 PHLPP1 CDK5RAP2 HERC1 RPA3 L3MBTL3 GCN1 AGTPBP1 PCNT | 2.13e-10 | 1049 | 152 | 23 | 27880917 | |
| Pubmed | MID2 ACLY ERO1A SERPINH1 CLCC1 EDEM3 GSPT2 P4HB TMEM131 TTC13 HERC1 GCN1 PCNT | 4.54e-10 | 285 | 152 | 13 | 32838362 | |
| Pubmed | 5.22e-09 | 6 | 152 | 4 | 32527940 | ||
| Pubmed | 5.22e-09 | 6 | 152 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.21e-08 | 7 | 152 | 4 | 8467709 | |
| Pubmed | 1.21e-08 | 7 | 152 | 4 | 8464825 | ||
| Pubmed | 1.21e-08 | 7 | 152 | 4 | 27514509 | ||
| Pubmed | 2.42e-08 | 8 | 152 | 4 | 20610558 | ||
| Pubmed | 2.42e-08 | 8 | 152 | 4 | 18052087 | ||
| Pubmed | 2.42e-08 | 8 | 152 | 4 | 17179145 | ||
| Pubmed | ACLY RSF1 CKAP5 SRP72 CHD1 DDX51 SERPINH1 GFPT1 RIF1 PBRM1 DST P4HB AHNAK PDCD11 GCN1 PCNT | 3.22e-08 | 653 | 152 | 16 | 22586326 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ERO1A SRP72 ZYG11B EXOSC2 CLCC1 GSPT1 FANCD2 EDEM3 IBTK STXBP3 SBNO1 P4HB GORASP1 CDK5RAP2 MTX1 GCN1 PCNT | 3.89e-08 | 754 | 152 | 17 | 33060197 |
| Pubmed | 4.34e-08 | 9 | 152 | 4 | 22511988 | ||
| Pubmed | 7.22e-08 | 10 | 152 | 4 | 23642732 | ||
| Pubmed | 7.22e-08 | 10 | 152 | 4 | 11465080 | ||
| Pubmed | 7.22e-08 | 10 | 152 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 7.22e-08 | 10 | 152 | 4 | 22558097 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 12847094 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 29519853 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.69e-07 | 12 | 152 | 4 | 20308471 | |
| Pubmed | 1.69e-07 | 12 | 152 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.69e-07 | 12 | 152 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 2.43e-07 | 13 | 152 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 2.43e-07 | 13 | 152 | 4 | 25246029 | |
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 17558305 | ||
| Pubmed | 3.39e-07 | 14 | 152 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 3.39e-07 | 14 | 152 | 4 | 10836148 | |
| Pubmed | 3.39e-07 | 14 | 152 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 3.39e-07 | 14 | 152 | 4 | 14672974 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ACLY ERO1A NIF3L1 SRP72 VPS26A SERPINH1 ME1 EXOSC2 GFPT1 GSPT1 IWS1 FANCD2 S100A13 GSPT2 SBNO1 P4HB ASMTL AHNAK HERC1 SEPTIN7 RPA3 GCN1 | 4.00e-07 | 1455 | 152 | 22 | 22863883 |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 6.13e-07 | 16 | 152 | 4 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 7.98e-07 | 17 | 152 | 4 | 20639394 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 20565459 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 15057901 | ||
| Pubmed | 1.02e-06 | 18 | 152 | 4 | 20056724 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PRKD2 ACLY ERO1A CKAP5 SRP72 CHD1 MAST2 SERPINH1 GFPT1 NDUFV1 GSPT1 FANCD2 RIF1 PBRM1 STXBP3 SBNO1 P4HB INTS11 PDCD11 SEPTIN7 GCN1 | 1.14e-06 | 1425 | 152 | 21 | 30948266 |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.29e-06 | 19 | 152 | 4 | 23281178 | |
| Pubmed | 1.79e-06 | 130 | 152 | 7 | 12421765 | ||
| Pubmed | ST7 ERO1A CHD1 NDUFV1 CLCC1 SH3BP4 EFR3A STXBP3 P4HB PDCD11 CDK5RAP2 TMEM131 TTC13 C9orf72 MAP2K1 EIF2AK3 DCXR MRPL1 AGTPBP1 MAST3 PCNT | 2.22e-06 | 1487 | 152 | 21 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ST7 RNF213 SRP72 NDUFV1 CLCC1 FANCD2 IBTK DST ATXN3 PDCD11 CDK5RAP2 TMEM131 TTC13 HERC1 C9orf72 MTX1 RPA3 EIF2AK3 DCXR MRPL1 PCNT | 2.44e-06 | 1496 | 152 | 21 | 32877691 |
| Pubmed | 2.91e-06 | 23 | 152 | 4 | 26002199 | ||
| Pubmed | DOCK1 ABL2 ACLY CKAP5 SRP72 GFPT1 CLCC1 DENND4C EFR3A DST AHNAK SEPTIN7 GCN1 EIF2AK3 | 3.04e-06 | 708 | 152 | 14 | 39231216 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 3.48e-06 | 24 | 152 | 4 | 24625756 | |
| Pubmed | PRKD2 CKAP5 VPS26A RAD54L2 GFPT1 ME3 MAGI2 ZNF18 DST SBNO1 COG1 ASB3 OSBPL1A MKLN1 TMEM131 PCMTD2 SEPTIN7 AGTPBP1 PCNT | 3.67e-06 | 1285 | 152 | 19 | 35914814 | |
| Pubmed | EP400 ERO1A RNF213 CHD1 CLCC1 DENND4C EDEM3 IBTK ARID1B CNOT6L STXBP3 TMEM131 TTC13 AGTPBP1 | 4.52e-06 | 733 | 152 | 14 | 34672954 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DPYSL5 ZYG11B EXOSC2 DENND4C SH3BP4 RIF1 CNOT6L SBNO1 NEK5 P4HB AHNAK OSBPL1A MKLN1 SNAPC1 SEPTIN7 RPA3 GCN1 MAST3 ARHGAP19 | 5.45e-06 | 1321 | 152 | 19 | 27173435 |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 6.74e-06 | 9 | 152 | 3 | 20732626 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 7.10e-06 | 298 | 152 | 9 | 32353859 | |
| Pubmed | EP400 RSF1 CHD1 KNOP1 IWS1 IBTK PBRM1 AHNAK PCMTD2 L3MBTL3 GCN1 | 7.51e-06 | 469 | 152 | 11 | 27634302 | |
| Pubmed | EP400 CKAP5 SRP72 CHD1 DDX51 SERPINH1 EXOSC2 NDUFV1 KNOP1 IWS1 EFR3A GREB1L RIF1 PBRM1 DST CNOT6L P4HB ATXN7 INTS11 PDCD11 | 8.99e-06 | 1497 | 152 | 20 | 31527615 | |
| Pubmed | TCF4 EP400 SERPINH1 GSPT1 FANCD2 IBTK ARID1B PBRM1 PCMTD2 GCN1 | 1.05e-05 | 396 | 152 | 10 | 26687479 | |
| Pubmed | DOCK1 ACLY CHD1 SERPINH1 CLCC1 GSPT1 KNOP1 S100A13 RIF1 P4HB SYDE2 AHNAK SEPTIN7 GCN1 ARHGAP19 | 1.28e-05 | 916 | 152 | 15 | 32203420 | |
| Pubmed | 1.32e-05 | 11 | 152 | 3 | 18695635 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 1.63e-05 | 182 | 152 | 7 | 31067453 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.68e-05 | 332 | 152 | 9 | 32786267 | |
| Pubmed | ST7 ERO1A RNF213 SRP72 SERPINH1 EXOSC2 CLCC1 GSPT1 IWS1 FANCD2 DST CNOT6L COG1 AHNAK PDCD11 PCMTD2 RPA3 GCN1 MRPL1 | 1.82e-05 | 1440 | 152 | 19 | 30833792 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 38892470 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 15987998 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 3678603 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 33619771 | ||
| Pubmed | Functional roles of the tetramer organization of malic enzyme. | 1.90e-05 | 2 | 152 | 2 | 19416979 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 11677206 | ||
| Pubmed | Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. | 1.90e-05 | 2 | 152 | 2 | 12944423 | |
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 1.90e-05 | 2 | 152 | 2 | 10497143 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 12944498 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 17529886 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 26210447 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 25547628 | ||
| Pubmed | Importance of the CEP215-pericentrin interaction for centrosome maturation during mitosis. | 1.90e-05 | 2 | 152 | 2 | 24466316 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 11901093 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 22031623 | ||
| Pubmed | Centriole-independent mitotic spindle assembly relies on the PCNT-CDK5RAP2 pericentriolar matrix. | 1.90e-05 | 2 | 152 | 2 | 33170211 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 1.90e-05 | 2 | 152 | 2 | 17603215 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 15709193 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 34074138 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 34916487 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 24981173 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 9647757 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 20089735 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 27703014 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EP400 ACLY RSF1 CKAP5 CHD1 DDX51 VPS26A SERPINH1 GFPT1 GSPT1 RIF1 DST ARVCF P4HB AHNAK INTS11 PDCD11 GCN1 | 2.76e-05 | 1353 | 152 | 18 | 29467282 |
| Pubmed | EP400 RNF213 CLCC1 KNOP1 SH3BP4 CASP12 RIF1 DST SYDE2 AHNAK CDK5RAP2 DEPDC7 GCN1 | 3.98e-05 | 777 | 152 | 13 | 35844135 | |
| Pubmed | EP400 RSF1 RNF213 CHD1 SERPINH1 EXOSC2 GFPT1 IWS1 FANCD2 RIF1 PBRM1 SBNO1 AHNAK UPP1 RPA3 | 4.11e-05 | 1014 | 152 | 15 | 32416067 | |
| Pubmed | 4.74e-05 | 215 | 152 | 7 | 35973513 | ||
| Pubmed | 5.32e-05 | 17 | 152 | 3 | 21897333 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK1 CKAP5 SRP72 GSPT1 FANCD2 RIF1 AHNAK SEPTIN7 DEPDC7 GCN1 PCNT | 5.43e-05 | 582 | 152 | 11 | 20467437 |
| Pubmed | ACLY ERO1A NIF3L1 SRP72 SERPINH1 EXOSC2 GFPT1 NDUFV1 EDEM3 DST P4HB AHNAK PDCD11 TTC13 SEPTIN7 MAP2K1 DCXR | 5.62e-05 | 1297 | 152 | 17 | 33545068 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 20682599 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 16636344 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 5.68e-05 | 3 | 152 | 2 | 20007669 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 19244109 | ||
| Pubmed | Triple deletion of TP53, PCNT, and CEP215 promotes centriole amplification in the M phase. | 5.68e-05 | 3 | 152 | 2 | 34233584 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 15542627 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 32587773 | ||
| Pubmed | Polypeptide chain release factor eRF3 is a novel molecular partner of survivin. | 5.68e-05 | 3 | 152 | 2 | 23377885 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 23919619 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 19225446 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 23636243 | ||
| Pubmed | Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13. | 5.68e-05 | 3 | 152 | 2 | 18492805 | |
| Interaction | FPR1 interactions | 1.42e-06 | 147 | 148 | 9 | int:FPR1 | |
| Cytoband | 2q37 | 3.39e-06 | 31 | 152 | 4 | 2q37 | |
| GeneFamily | UDP glucuronosyltransferases | 1.78e-05 | 32 | 89 | 4 | 363 | |
| GeneFamily | Ataxins|MJD deubiquinating enzymes | 3.55e-04 | 6 | 89 | 2 | 411 | |
| GeneFamily | PDZ domain containing | 9.25e-04 | 152 | 89 | 5 | 1220 | |
| GeneFamily | Secretoglobins | 2.10e-03 | 14 | 89 | 2 | 734 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | DOCK1 RSF1 SLC10A7 GFPT1 EFR3A IBTK RIF1 C17orf75 SBNO1 ATXN3 MKLN1 AGTPBP1 | 3.12e-06 | 330 | 146 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | DOCK1 RSF1 SLC10A7 GFPT1 GSPT1 EFR3A IBTK C17orf75 ATXN3 MKLN1 L3MBTL3 GCN1 AGTPBP1 | 3.77e-06 | 397 | 146 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.22e-06 | 179 | 146 | 9 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | DOCK1 SLC10A7 GFPT1 EFR3A IBTK C17orf75 ATXN3 MKLN1 L3MBTL3 AGTPBP1 | 4.65e-06 | 231 | 146 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | DOCK1 TCF4 RSF1 CKAP5 CHD1 ZYG11B HEATR5A GSPT1 IWS1 RIF1 DST COG1 TMEM131 | 2.23e-05 | 469 | 146 | 13 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.14e-05 | 230 | 146 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | DOCK1 CHD1 SLC10A7 LDAH GFPT1 EFR3A IBTK MKLN1 L3MBTL3 GCN1 AGTPBP1 | 5.08e-05 | 369 | 146 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_500 | 1.32e-04 | 113 | 146 | 6 | gudmap_developingGonad_e16.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.40e-04 | 219 | 146 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | RSF1 TOGARAM1 CHD1 GFPT1 PCDH20 IWS1 RIF1 CNOT6L STXBP3 OSBPL1A CMTR2 L3MBTL3 | 1.56e-04 | 492 | 146 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | DPYSL5 GSPT2 STXBP3 ARVCF SYT11 INTS11 PHLPP1 C9orf72 ALG6 PHTF1 | 1.59e-04 | 350 | 146 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | TCF4 DPYSL5 ME1 KNOP1 GREB1L DST GSPT2 MAPK12 ARVCF SYT11 ATXN3 PHLPP1 | 1.65e-04 | 495 | 146 | 12 | Facebase_RNAseq_e8.5_Floor Plate_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | TCF4 RSF1 DPYSL5 LHPP HEATR5A ME1 KNOP1 GREB1L DST GSPT2 MAPK12 ARVCF SYT11 ATXN3 PHLPP1 PLAGL2 MTX1 GCN1 | 1.66e-04 | 994 | 146 | 18 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.00e-04 | 122 | 146 | 6 | Facebase_RNAseq_e8.5_Floor Plate_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TCF4 RSF1 TOGARAM1 CHD1 GFPT1 PCDH20 IWS1 MAGI2 RIF1 DST CNOT6L STXBP3 OSBPL1A DDX3Y CMTR2 L3MBTL3 | 2.11e-04 | 836 | 146 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000 | DOCK1 PRKD2 TCF4 MID2 RNF213 F8 DPH6 CASP12 S100A13 MAPK12 STXBP3 AHNAK PHLPP1 DDX3Y UPP1 NR3C2 | 2.55e-04 | 850 | 146 | 16 | gudmap_kidney_adult_RenMedVasc_Tie2_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | ABL2 RNF213 SRP72 PIWIL2 MSH4 GREB1L MAGI2 RIF1 CNOT6L STXBP3 SBNO1 DDX3Y PCMTD2 HERC1 C9orf72 | 3.11e-04 | 778 | 146 | 15 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.54e-04 | 251 | 146 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 1.97e-08 | 190 | 152 | 9 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 2.38e-07 | 184 | 152 | 8 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | Control-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 2.81e-07 | 188 | 152 | 8 | 47126c371a242c937499fd278a74a882df8f759c | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 3.04e-07 | 190 | 152 | 8 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.43e-07 | 193 | 152 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 3.43e-07 | 193 | 152 | 8 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 3.57e-07 | 194 | 152 | 8 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 3.71e-07 | 195 | 152 | 8 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 4.00e-06 | 189 | 152 | 7 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.00e-06 | 189 | 152 | 7 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | IPF-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.00e-06 | 189 | 152 | 7 | ad7bb3a7de8e48c145e4382f90d30bb2159c2b76 | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 4.14e-06 | 190 | 152 | 7 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | IPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class | 4.43e-06 | 192 | 152 | 7 | e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.43e-06 | 192 | 152 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 4.43e-06 | 192 | 152 | 7 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-06 | 200 | 152 | 7 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.79e-06 | 200 | 152 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.08e-05 | 175 | 152 | 6 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-05 | 176 | 152 | 6 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.72e-05 | 181 | 152 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.60e-05 | 188 | 152 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.73e-05 | 189 | 152 | 6 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | IPF-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.73e-05 | 189 | 152 | 6 | 5c22d2d935f7bb270260b8bc6be67b565ec401bf | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | 5a0fd34928117f162c83ca1b068aa8f7069a6765 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.73e-05 | 189 | 152 | 6 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 189 | 152 | 6 | 0493f7b79127c207fd7ade778ef4810500495d7e | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.87e-05 | 190 | 152 | 6 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | IPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 4.87e-05 | 190 | 152 | 6 | f9c2a13c7f6460e3b348581be855b7281c8f70b5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.02e-05 | 191 | 152 | 6 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 192 | 152 | 6 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 192 | 152 | 6 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.32e-05 | 193 | 152 | 6 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | Macrophages-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 5.47e-05 | 194 | 152 | 6 | 54fda501ce1d041285d04c3c96c15983f454bed4 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 5.63e-05 | 195 | 152 | 6 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | mLN-T_cell-gd_T|T_cell / Region, Cell class and subclass | 5.79e-05 | 196 | 152 | 6 | 8f476408cd5a4ea9d25c763c66565343d7989b38 | |
| ToppCell | mLN-(1)_T_cell-(17)_gd_T|mLN / shred on region, Cell_type, and subtype | 5.96e-05 | 197 | 152 | 6 | 5c781ded147db2f3804ee1f21ef0898c4f354890 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.96e-05 | 197 | 152 | 6 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | mLN-T_cell-gd_T|mLN / Region, Cell class and subclass | 5.96e-05 | 197 | 152 | 6 | 8ef03bdbd34a874671aebfdbb7111106aa37b2a9 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.96e-05 | 197 | 152 | 6 | 3cd1c816bc7a57278b2ef615b69545356ab8f522 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.30e-05 | 199 | 152 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.48e-05 | 200 | 152 | 6 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.48e-05 | 200 | 152 | 6 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l14|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.02e-05 | 132 | 152 | 5 | 14a512f433315892bf0326419f23d0d5919d01ec | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.69e-05 | 134 | 152 | 5 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.04e-04 | 136 | 152 | 5 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| Drug | naringenin chalcone | 8.53e-09 | 5 | 148 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 8.53e-09 | 5 | 148 | 4 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 2.55e-08 | 6 | 148 | 4 | ctd:C543211 | |
| Drug | alloin | 2.55e-08 | 6 | 148 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 2.55e-08 | 6 | 148 | 4 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 5.91e-08 | 7 | 148 | 4 | ctd:C059354 | |
| Drug | SureCN12722713 | 8.68e-08 | 18 | 148 | 5 | CID005488034 | |
| Drug | 1,4-dihydroxyanthraquinone | 1.18e-07 | 8 | 148 | 4 | ctd:C034890 | |
| Drug | tectochrysin | 1.55e-07 | 20 | 148 | 5 | CID005281954 | |
| Drug | AC1MRQNQ | 2.11e-07 | 9 | 148 | 4 | CID003522271 | |
| Drug | DHPASiU | 2.11e-07 | 9 | 148 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 2.11e-07 | 9 | 148 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 2.11e-07 | 9 | 148 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 2.11e-07 | 9 | 148 | 4 | CID005460873 | |
| Drug | 2,6-dihydroxyanthraquinone | 3.49e-07 | 10 | 148 | 4 | ctd:C034889 | |
| Drug | 4-nitrophenyl)imidazole | 5.46e-07 | 11 | 148 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 5.46e-07 | 11 | 148 | 4 | CID006442661 | |
| Drug | UDP-glucose | MGAM HCAR2 UGT1A10 UGT1A8 UGT1A7 UGT1A9 NIF3L1 GFPT1 AIF1 UPP1 ALG6 | 6.78e-07 | 247 | 148 | 11 | CID000001166 |
| Drug | AC1L1G0K | 7.57e-07 | 49 | 148 | 6 | CID000003473 | |
| Drug | N-OH-DABZ | 8.15e-07 | 12 | 148 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 8.15e-07 | 12 | 148 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 8.15e-07 | 12 | 148 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 8.15e-07 | 12 | 148 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 8.15e-07 | 12 | 148 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 8.15e-07 | 12 | 148 | 4 | CID000276709 | |
| Drug | erucin | 9.45e-07 | 28 | 148 | 5 | CID000078160 | |
| Drug | hydratropic acid | 1.07e-06 | 4 | 148 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 1.07e-06 | 4 | 148 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 1.07e-06 | 4 | 148 | 3 | ctd:C037760 | |
| Drug | AC1L1JAL | 1.14e-06 | 29 | 148 | 5 | CID000004954 | |
| Drug | iberin | 1.14e-06 | 29 | 148 | 5 | CID000010455 | |
| Drug | 2-hydroxyestrone | 1.17e-06 | 13 | 148 | 4 | ctd:C024980 | |
| Drug | tritanol | 1.17e-06 | 13 | 148 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.17e-06 | 13 | 148 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.17e-06 | 13 | 148 | 4 | CID000000411 | |
| Drug | alizarin | 1.17e-06 | 13 | 148 | 4 | ctd:C010078 | |
| Drug | 4-ethylphenol | 1.61e-06 | 31 | 148 | 5 | CID000031242 | |
| Drug | propranolol glucuronide | 1.63e-06 | 14 | 148 | 4 | CID000119515 | |
| Drug | PCB-61 | 1.63e-06 | 14 | 148 | 4 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.21e-06 | 15 | 148 | 4 | CID000040469 | |
| Drug | afloqualone | 2.21e-06 | 15 | 148 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 2.21e-06 | 15 | 148 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 2.21e-06 | 15 | 148 | 4 | CID000010752 | |
| Drug | bergamottin | 2.21e-06 | 15 | 148 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 2.21e-06 | 15 | 148 | 4 | CID000543743 | |
| Drug | AC1Q6OQG | 2.22e-06 | 33 | 148 | 5 | CID000009686 | |
| Drug | isovaleric acid | 2.67e-06 | 5 | 148 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 2.67e-06 | 5 | 148 | 3 | ctd:C012776 | |
| Drug | quercetin-3,4'-diglucoside | 2.94e-06 | 16 | 148 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.94e-06 | 16 | 148 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.94e-06 | 16 | 148 | 4 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 3.82e-06 | 17 | 148 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 3.82e-06 | 17 | 148 | 4 | CID000037766 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 4.89e-06 | 18 | 148 | 4 | CID000152226 | |
| Drug | Br 2 | 4.89e-06 | 18 | 148 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 4.89e-06 | 18 | 148 | 4 | CID000036614 | |
| Drug | ApApG | 4.89e-06 | 18 | 148 | 4 | CID003081975 | |
| Drug | C1 11-32 | 4.89e-06 | 18 | 148 | 4 | CID000443077 | |
| Drug | C11131 | 4.89e-06 | 18 | 148 | 4 | CID000443076 | |
| Drug | 3-phenylpropionic acid | 5.31e-06 | 6 | 148 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 5.31e-06 | 6 | 148 | 3 | ctd:D007216 | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; HL60; HG-U133A | 5.42e-06 | 195 | 148 | 9 | 1370_UP | |
| Drug | 9-OH-risperidone | 6.16e-06 | 19 | 148 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 6.16e-06 | 19 | 148 | 4 | CID000091433 | |
| Drug | almokalant | 6.16e-06 | 19 | 148 | 4 | CID003033962 | |
| Drug | nitrosamine | 6.34e-06 | 70 | 148 | 6 | CID000037183 | |
| Drug | AC1L1OBF | 7.66e-06 | 20 | 148 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 7.66e-06 | 20 | 148 | 4 | CID000116545 | |
| Drug | entacapone | 7.66e-06 | 20 | 148 | 4 | ctd:C071192 | |
| Drug | Woodward's reagent K | 8.56e-06 | 43 | 148 | 5 | CID000077804 | |
| Drug | estriol-16-glucuronide | 9.41e-06 | 21 | 148 | 4 | CID000122281 | |
| Drug | dulcin | 9.41e-06 | 21 | 148 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 9.41e-06 | 21 | 148 | 4 | CID000069186 | |
| Drug | amonafide | 1.14e-05 | 22 | 148 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 1.14e-05 | 22 | 148 | 4 | CID000053167 | |
| Drug | plumbagin | 1.14e-05 | 22 | 148 | 4 | ctd:C014758 | |
| Drug | amidoxime | 1.38e-05 | 23 | 148 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.38e-05 | 23 | 148 | 4 | CID000066651 | |
| Drug | phenanthridine | 1.38e-05 | 23 | 148 | 4 | CID000009189 | |
| Drug | glabridin | 1.47e-05 | 8 | 148 | 3 | ctd:C107601 | |
| Drug | isoamyl alcohol | 1.48e-05 | 48 | 148 | 5 | CID000031260 | |
| Drug | cinnamic acid | 1.65e-05 | 24 | 148 | 4 | ctd:C029010 | |
| Drug | AS-3201 | 1.65e-05 | 24 | 148 | 4 | CID000153948 | |
| Drug | 5-MOP | 1.95e-05 | 25 | 148 | 4 | CID000002355 | |
| Drug | Hymecromone | 1.95e-05 | 25 | 148 | 4 | ctd:D006923 | |
| Drug | AzMC | 1.95e-05 | 25 | 148 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 1.95e-05 | 25 | 148 | 4 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 1.95e-05 | 25 | 148 | 4 | CID000006796 | |
| Drug | N-phenylmaleimide | 1.95e-05 | 25 | 148 | 4 | CID000013662 | |
| Drug | 7-ethoxycoumarin | 2.09e-05 | 86 | 148 | 6 | CID000035703 | |
| Drug | AC1L1FK5 | 2.19e-05 | 129 | 148 | 7 | CID000003272 | |
| Drug | AC1NQGK1 | 2.20e-05 | 52 | 148 | 5 | CID005195977 | |
| Drug | Thymol | 2.29e-05 | 26 | 148 | 4 | ctd:D013943 | |
| Drug | ASA404 | 2.42e-05 | 53 | 148 | 5 | CID000123964 | |
| Drug | DEPC | 2.42e-05 | 53 | 148 | 5 | CID000015357 | |
| Drug | luteolin | 2.42e-05 | 131 | 148 | 7 | CID005280445 | |
| Drug | tangeretin | 2.65e-05 | 54 | 148 | 5 | CID000068077 | |
| Drug | Equol | 2.65e-05 | 54 | 148 | 5 | ctd:D060754 | |
| Drug | licochalcone A | 2.68e-05 | 27 | 148 | 4 | ctd:C070840 | |
| Drug | diflunisal | 2.68e-05 | 27 | 148 | 4 | CID000003059 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 3.20e-09 | 5 | 150 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 3.20e-09 | 5 | 150 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 3.20e-09 | 5 | 150 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 2.22e-08 | 7 | 150 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 4.42e-08 | 8 | 150 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 7.93e-08 | 9 | 150 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 7.93e-08 | 9 | 150 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 7.93e-08 | 9 | 150 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 7.93e-08 | 9 | 150 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 7.93e-08 | 9 | 150 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 7.93e-08 | 9 | 150 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 7.93e-08 | 9 | 150 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 7.93e-08 | 9 | 150 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 7.93e-08 | 9 | 150 | 4 | EFO_0004570, GO_0009410 | |
| Disease | indole-3-carboxylate measurement | 1.29e-07 | 3 | 150 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.29e-07 | 3 | 150 | 3 | EFO_0022216 | |
| Disease | bilirubin measurement, response to tenofovir | 1.32e-07 | 10 | 150 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.32e-07 | 10 | 150 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.32e-07 | 10 | 150 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.32e-07 | 10 | 150 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 2.06e-07 | 11 | 150 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 2.06e-07 | 11 | 150 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 2.06e-07 | 11 | 150 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.06e-07 | 11 | 150 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.06e-07 | 11 | 150 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.06e-07 | 11 | 150 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 3.08e-07 | 12 | 150 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 3.08e-07 | 12 | 150 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 4.43e-07 | 13 | 150 | 4 | EFO_0800587 | |
| Disease | X-24588 measurement | 4.43e-07 | 13 | 150 | 4 | EFO_0800898 | |
| Disease | retinol dehydrogenase 16 measurement | 4.43e-07 | 13 | 150 | 4 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.45e-06 | 17 | 150 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 1.45e-06 | 17 | 150 | 4 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 1.86e-06 | 18 | 150 | 4 | EFO_0801382 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 2.55e-06 | 6 | 150 | 3 | EFO_0800566 | |
| Disease | tissue factor measurement | 3.59e-06 | 21 | 150 | 4 | EFO_0010623 | |
| Disease | hormone measurement | 4.58e-06 | 84 | 150 | 6 | EFO_0004730 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.19e-05 | 28 | 150 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 1.38e-05 | 29 | 150 | 4 | EFO_0010551 | |
| Disease | indoleacetate measurement | 1.51e-05 | 10 | 150 | 3 | EFO_0021015 | |
| Disease | response to dolutegravir | 1.59e-05 | 30 | 150 | 4 | EFO_0600017 | |
| Disease | Paranoia | 2.06e-05 | 11 | 150 | 3 | C1456784 | |
| Disease | vitamin D deficiency | 3.72e-05 | 37 | 150 | 4 | EFO_0003762 | |
| Disease | cholelithiasis | 8.86e-05 | 88 | 150 | 5 | EFO_0004799 | |
| Disease | vitamin D measurement, COVID-19 | 1.14e-04 | 49 | 150 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | late-onset Alzheimers disease | 1.31e-04 | 292 | 150 | 8 | EFO_1001870 | |
| Disease | autoimmune disease (implicated_via_orthology) | 1.53e-04 | 4 | 150 | 2 | DOID:417 (implicated_via_orthology) | |
| Disease | Machado-Joseph disease (implicated_via_orthology) | 1.53e-04 | 4 | 150 | 2 | DOID:1440 (implicated_via_orthology) | |
| Disease | urate measurement, spine bone mineral density | 2.20e-04 | 58 | 150 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | gallstones | 2.32e-04 | 108 | 150 | 5 | EFO_0004210 | |
| Disease | Nonorganic psychosis | 4.29e-04 | 69 | 150 | 4 | C0349204 | |
| Disease | apolipoprotein B measurement | ANK1 UGT1A10 UGT1A8 UGT1A7 DPYSL5 UGT1A9 LDAH CLCC1 STXBP3 PCMTD2 L3MBTL3 | 6.03e-04 | 663 | 150 | 11 | EFO_0004615 |
| Disease | restless legs syndrome (implicated_via_orthology) | 7.04e-04 | 8 | 150 | 2 | DOID:0050425 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A9 PBRM1 SBNO1 SYT11 AHNAK L3MBTL3 GCN1 ALPK2 MAST3 EPHA1 | 8.22e-04 | 914 | 150 | 13 | EFO_0004532 |
| Disease | thyroxine measurement | 8.63e-04 | 83 | 150 | 4 | EFO_0005130 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 9.50e-04 | 147 | 150 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Moyamoya disease | 1.11e-03 | 40 | 150 | 3 | MONDO_0016820 | |
| Disease | Liver carcinoma | 1.19e-03 | 507 | 150 | 9 | C2239176 | |
| Disease | bitter beverage consumption measurement | 1.28e-03 | 42 | 150 | 3 | EFO_0010089 | |
| Disease | Major Depressive Disorder | 1.56e-03 | 243 | 150 | 6 | C1269683 | |
| Disease | dodecanedioate measurement | 1.64e-03 | 12 | 150 | 2 | EFO_0021054 | |
| Disease | urinary bladder carcinoma | 1.77e-03 | 47 | 150 | 3 | MONDO_0004986 | |
| Disease | Psychotic Disorders | 1.79e-03 | 101 | 150 | 4 | C0033975 | |
| Disease | cardiac troponin I measurement | 2.10e-03 | 176 | 150 | 5 | EFO_0010071 | |
| Disease | Unipolar Depression | 2.16e-03 | 259 | 150 | 6 | C0041696 | |
| Disease | sitting height ratio | 2.24e-03 | 51 | 150 | 3 | EFO_0007118 | |
| Disease | metabolite measurement | 2.34e-03 | 560 | 150 | 9 | EFO_0004725 | |
| Disease | anti-neutrophil antibody associated vasculitis | 2.37e-03 | 52 | 150 | 3 | EFO_0004826 | |
| Disease | sleep apnea measurement | 2.96e-03 | 116 | 150 | 4 | EFO_0007817 | |
| Disease | open-angle glaucoma | 2.99e-03 | 191 | 150 | 5 | EFO_0004190 | |
| Disease | lymphocyte count | TCF4 ANK1 JDP2 ME3 PBRM1 ARVCF SBNO1 SCGB1C2 SYT11 AHNAK ASB3 PHLPP1 NR3C2 L3MBTL3 PHTF1 SCGB1C1 | 3.26e-03 | 1464 | 150 | 16 | EFO_0004587 |
| Disease | Moyamoya Disease | 3.32e-03 | 17 | 150 | 2 | C0026654 | |
| Disease | non-high density lipoprotein cholesterol measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A9 HEATR5A DENND4C PBRM1 SBNO1 MTX1 L3MBTL3 | 3.62e-03 | 713 | 150 | 10 | EFO_0005689 |
| Disease | leukemia (implicated_via_orthology) | 4.15e-03 | 19 | 150 | 2 | DOID:1240 (implicated_via_orthology) | |
| Disease | tea consumption measurement | 4.32e-03 | 129 | 150 | 4 | EFO_0010091 | |
| Disease | Drug-Induced Liver Disease | 4.73e-03 | 404 | 150 | 7 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 4.73e-03 | 404 | 150 | 7 | C3658290 | |
| Disease | Hepatitis, Toxic | 4.73e-03 | 404 | 150 | 7 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 4.73e-03 | 404 | 150 | 7 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 4.73e-03 | 404 | 150 | 7 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 4.73e-03 | 404 | 150 | 7 | C1262760 | |
| Disease | pulse pressure measurement | TCF4 CKAP5 RNF213 HEATR5A MAST2 LDAH DENND4C ARID1B PBRM1 ARVCF ATXN7 ASB3 INTS11 MKLN1 CMTR2 | 4.97e-03 | 1392 | 150 | 15 | EFO_0005763 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVLKARHLPKMDITG | 311 | Q9BT88 | |
| IKAVGKLTPEHLIKM | 2806 | Q96L91 | |
| LHLEGVVTKRKPIMI | 686 | P21709 | |
| VILGLQEKHLKADIM | 2441 | Q96N23 | |
| PLKMVIIDHGLQTLT | 476 | O00192 | |
| LLMDPELHVGKCKIE | 376 | Q86XM0 | |
| NLLPEDEMIGKIIKH | 76 | Q96M83 | |
| VMREVKALAKLEHPG | 636 | Q9NZJ5 | |
| ITGLPLIKEALIHMD | 91 | P51589 | |
| MKEIKHPNLVQLLGV | 336 | P42684 | |
| LKIKDILPRHIQLIM | 286 | Q9Y672 | |
| FLISHKMEEPKIEVL | 1621 | Q86TB3 | |
| GHVKMVVELLHKEII | 56 | P16157 | |
| MIIKVAALGLDPDKH | 161 | Q7L8W6 | |
| KGREAIHPLLSKMTL | 321 | Q8IYT2 | |
| LHLKAPKISMPEVDL | 4586 | Q09666 | |
| AMETGLLPNHKLKTV | 141 | Q8NFD5 | |
| KIPGTLHKIVSVKLM | 421 | Q96QD5 | |
| PKMVLLFHLIEESVK | 721 | Q9Y4B4 | |
| PSNGVLVHMVKLLIK | 6 | Q6UXS9 | |
| LMVQIHSILAKIGPK | 131 | Q9UPW5 | |
| SMLKEPALTLGKQIH | 126 | Q9H816 | |
| IKMDPDLSLTHKILP | 1276 | O14646 | |
| LHMVAKLLESGEPKL | 101 | Q14156 | |
| VHLVKMVILTEPEGA | 126 | Q76LX8 | |
| GAKKLMLELPLVIGT | 301 | Q8NCT1 | |
| KHVKILGPLAPEMID | 1181 | Q96SN8 | |
| GLVMARKLIHLEIKP | 91 | Q02750 | |
| MVLVPSLLHTEAPKK | 31 | P20742 | |
| LPAVVMHLKKQDLKE | 591 | Q96ST2 | |
| TDIVKIMSIKLGPAL | 746 | Q96JM7 | |
| THKSLTLGIPMLKIV | 276 | Q0GE19 | |
| LEVQIPLKGKIDLHM | 926 | Q8N6Y1 | |
| IILEPMDLKIIEHNI | 561 | Q86U86 | |
| HLIVMALEKEGLPKE | 311 | P48163 | |
| IMKVLLLLSTIPKDG | 871 | P08235 | |
| IHVGKVLPKTGLLMT | 121 | Q9BZ81 | |
| MPHADIVKLIKDAGL | 986 | Q86UL8 | |
| PKLDQALVVEHIEKM | 416 | Q7LDG7 | |
| EPESVLLVHGEAKKM | 406 | Q5TA45 | |
| IGLTVHLLKKKMPIQ | 156 | Q8TDS4 | |
| LEMPIHSDILKVILD | 811 | Q9P2D0 | |
| NHEMVLKDVLPPIIK | 2701 | Q03001 | |
| MVLCPVIGKLLHKRV | 1 | O95671 | |
| KVEMELPGDKIGLHL | 801 | O43451 | |
| ELGRMVQLHLKSDKP | 586 | P15884 | |
| MHRPKLIGEELAQLK | 186 | P54252 | |
| PEHLEILKKMGVSLI | 586 | Q9BZQ6 | |
| MGVAIRTKKPLDLHL | 4586 | Q15751 | |
| MIAPLHFLEVKLGKR | 46 | Q8WYK2 | |
| VKHLIVLINKMDDPT | 341 | Q8IYD1 | |
| LKVGGILVMPLEEKL | 181 | Q9NV79 | |
| KKHVEPMAVRQLLLG | 21 | C9JC47 | |
| IIQEMLEEVGKPKHR | 166 | A6NFU8 | |
| EVILLEKMKHPNIVA | 51 | Q6P3R8 | |
| KVMALELGPHKIRVN | 161 | Q7Z4W1 | |
| IVVGALELHTEPMKL | 1056 | Q96JB1 | |
| LELHTEPMKLALSIE | 1061 | Q96JB1 | |
| KKHVEPMAVRQLLLG | 21 | P0CG43 | |
| IELDKMLLSKVKVPH | 251 | Q9BZL6 | |
| MITKTHKVDLGLPEK | 1 | Q1ED39 | |
| KVDLLAPMIIHGIKT | 2091 | P00451 | |
| VILPAVMLALKEKLG | 2111 | Q92616 | |
| VLMELEKPVLISLGK | 141 | Q9H008 | |
| FLEGKIKPHLMSQEL | 346 | P07237 | |
| KPLDLAQGAEMKHIL | 211 | Q9BXW6 | |
| HQIKDILKPEIMEEI | 266 | Q13868 | |
| GKHLESMRLPLVSDK | 1496 | Q9C091 | |
| DILLKIVKVEHEEMP | 361 | Q9HAS0 | |
| IEKLQHELSLMGPVV | 1746 | O95613 | |
| VKVEKIHPKMDGTLL | 256 | O15265 | |
| GVKHLIVLINKMDDP | 211 | P15170 | |
| TLIESHEGKPLKLMV | 151 | Q9BQQ3 | |
| HLGNVLVDMKLIDIK | 106 | Q9H7P6 | |
| VMEHVQTTLLLGKLP | 1041 | Q7Z442 | |
| RFHLLELEKGKMPID | 141 | A8K0S8 | |
| KKHVEPMAVRQLLLG | 21 | P0CG42 | |
| QMGHTKILDLLIPLT | 256 | Q9Y575 | |
| KGPKILDHLTMIDNK | 1771 | Q14008 | |
| PHGKGKIIMTLAEDL | 521 | Q86XA9 | |
| HKIKFIPEMVGPILE | 1076 | Q14185 | |
| GHALPKVTLQEMLKS | 761 | Q8WTW3 | |
| EMLKEEHKVAVLGVP | 21 | C9JQL5 | |
| KPLVVLHLVLEMGFS | 491 | Q8N8A6 | |
| EIRMLKKVVSVHPGD | 446 | P09172 | |
| MSLGKEVHDIIRVKL | 691 | Q86WZ0 | |
| HLGLLTPVERKMVSK | 291 | Q5VZ89 | |
| IEKKMLRLEGHGDPL | 101 | P08034 | |
| KMLLLEILHEIKSFP | 341 | Q96HE7 | |
| LKPDNLLITSMGHIK | 636 | Q6P0Q8 | |
| VLGLVHMDVVELLLK | 1011 | O60307 | |
| HLLVMALEKEGVPKA | 346 | Q16798 | |
| KHAIPIIKGKRDLMA | 206 | O15523 | |
| GEVPKELVELHLKLM | 61 | Q96T23 | |
| MPIKLKIGLRHPDAV | 246 | A3KN83 | |
| NIIMALAEKIKPGLH | 446 | Q96LT7 | |
| MIIGHVLPDKETSLV | 96 | Q9BPU6 | |
| PEMKGKVLTRLKHIV | 806 | Q9BXW9 | |
| LRFHLLELEKGKMPI | 56 | A6NDR6 | |
| MSLLEEKLLPVLVHT | 246 | Q13505 | |
| PKLPKCSLEMIDHIV | 171 | P32754 | |
| LPEIEKATLKMLLDH | 946 | Q5VT97 | |
| GIPSISIMLHELIKL | 111 | Q16831 | |
| ELHLGLDKMKNPITK | 916 | Q9P0V3 | |
| LPHLLKDVGSLDEKM | 46 | Q99584 | |
| GELKHGPLALVDKLM | 591 | Q06210 | |
| HPMLTDIHDKLVLKG | 206 | Q9UL63 | |
| LQKDVHKIEGRVLPM | 556 | Q8TC59 | |
| LMEITIKGLPQKVLG | 551 | Q5UIP0 | |
| EMSVPLKELIEKHAG | 291 | P49821 | |
| DGLQPMHKAELVKLL | 71 | P0DMR2 | |
| EKLQIVEMPLAHKLS | 251 | P50454 | |
| HTLELVDPLKIAMKN | 426 | O15457 | |
| HSGILPILKEIVEML | 636 | Q15477 | |
| LVSLMKTLHLEPLKA | 66 | O60811 | |
| LRSIEELKHKPGMVS | 396 | O76094 | |
| LEMKSLILPPEHILK | 421 | Q9NRC1 | |
| EILSLEKPLLLHTGM | 236 | Q9GZT8 | |
| HIAVVLEEIPKLMKE | 296 | O00186 | |
| LEKIHPTGKMFILSD | 31 | P35244 | |
| LLKIKTEPVDMLGLL | 246 | Q9UPG8 | |
| IHKEDKPLSLSMPVI | 331 | Q16533 | |
| LMTREKHPDGKILII | 326 | P53396 | |
| KRMLEKLGVPKTHLE | 71 | P55008 | |
| EFIKALMKEIPALLH | 321 | Q96S66 | |
| AGMKPIHAADKQLLI | 341 | Q96LI5 | |
| LELHEMIILKLKNPQ | 5131 | Q63HN8 | |
| IHPGMLLIGFVKSIK | 726 | Q14690 | |
| DVTGPMLLHKAKELA | 96 | Q6B0B8 | |
| PKMLELFKNGHEIKV | 231 | Q9BYD6 | |
| DLIAHLEQGKKPLTM | 51 | P35789 | |
| ALEKVHKVEDLLPIM | 646 | Q8NBP0 | |
| LTHVMEKTKPEILKL | 351 | Q9C0D3 | |
| EKLILRGHEVVVVMP | 46 | Q9HAW8 | |
| KKMGHIKPDLIDVDL | 41 | Q9UMS5 | |
| GLKPLDIEFMKRLHE | 171 | Q16181 | |
| VLMHGPKLKTIEGIV | 136 | Q86TD4 | |
| ILIHDVLLPEEAKTM | 466 | Q92545 | |
| LMIIKLTKPQDTKLH | 156 | Q8NCL8 | |
| ALSEHLKKPVSELLM | 221 | Q8TBZ2 | |
| LKKPVSELLMHTGET | 226 | Q8TBZ2 | |
| DGLQPMHKAELVKLL | 71 | Q8TD33 | |
| KMFLGELPEPLLTHK | 181 | Q14CB8 | |
| EKLILRGHEVVVVMP | 46 | O60656 | |
| VKLDEHIIPLGSMAI | 81 | Q68CL5 | |
| HMELQLIKKEITGIG | 206 | O75436 | |
| KMHVLPLIGGKVEEV | 581 | O60346 | |
| VMSGPHETLKQLRKL | 51 | P17022 | |
| PPHIKKSLEELLDMT | 1701 | Q9Y4F4 | |
| KEMLVDVPPHLKRLG | 641 | Q9UJV3 | |
| EKLILRGHEVVVVMP | 46 | Q9HAW7 | |
| EVPLSHKGKLMVTEE | 151 | Q6IPR3 | |
| EKLILRGHEVVVVMP | 46 | Q9HAW9 | |
| HLDQLKEIMKVTGTP | 231 | P53778 | |
| HVPKDMKLVLIGHSI | 126 | Q9H6V9 | |
| TELIMHIQKSLPLLE | 376 | P20592 |